- Home
- RARE vs STNG Comparison
RARE vs STNG Comparison
Compare RARE & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | STNG |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | Monaco |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RARE | STNG |
|---|---|---|
| Price | $23.40 | $57.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 6 |
| Target Price | ★ $73.11 | $70.17 |
| AVG Volume (30 Days) | ★ 4.0M | 1.0M |
| Earning Date | 02-12-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 2.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.88 |
| Revenue | $630,598,000.00 | ★ $889,539,000.00 |
| Revenue This Year | $19.68 | N/A |
| Revenue Next Year | $19.44 | N/A |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | ★ 20.63 | N/A |
| 52 Week Low | $18.41 | $30.63 |
| 52 Week High | $46.50 | $65.52 |
Technical Indicators
Market Signals| Indicator | RARE | STNG |
|---|---|---|
| Relative Strength Index (RSI) | 38.36 | 55.64 |
| Support Level | $22.00 | $57.80 |
| Resistance Level | $24.65 | $59.82 |
| Average True Range (ATR) | 1.28 | 2.17 |
| MACD | 0.19 | 0.62 |
| Stochastic Oscillator | 44.59 | 66.93 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.